Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Insight into Kallmann syndrome

The inherited disease Kallmann syndrome (KS) is characterized by gonadotropin-releasing hormone (GnRH) deficiency, hypogonadism, reproductive defects, and compromised olfaction. The relatively small number of patients with this disease has restricted the identification of KS-causing genes, resulting in a limited understanding of the pathobiology of KS. Using a multifaceted approach, Anna Cariboni and colleagues at University College London demonstrated that the class 3 semaphorin SEMA3E promotes survival of hypothalamic GnRH neurons. Whole exome sequencing of two brothers diagnosed with KS revealed the presence of a mutation in SEMA3E that was predicted by computer models to be deleterious for SEMA3E function. In a cell culture system, expression of KS-associated SEMA3E in GnRH neurons did not inhibit migration; however, KS-associated SEMA3E was unable to signal through the PLXND1 receptor, which promotes PI3K-dependent survival signaling, resulting in GnRH neuron apoptosis. In murine models, deletion of Sema3E, Plxnd1, or Kdr, which encodes a PLXND1 co-receptor, revealed that SEMA3E signaling is required for proper innervation of GnRH neurons into the adult median eminence. Additionally, mice with a disruption of SEMA3E signaling displayed a reduction in testes size, similar to human KS patients. In a companion Commentary, Shlomo Melmed at Cedars-Sinai Medical Center discusses the power of a combinatorial, multi-system approach to identify the functional consequences of genetic perturbations in hereditary endocrine disorders. The accompanying image shows coronal sections of the adult mouse hypothalamus and demonstrates that loss of SEMA3E (right) markedly reduces the innervation of GnRH-positive neuron projections (green) into the median eminence. Sections counterstained with DAPI (blue).

Published May 18, 2015, by Nicole M. Baker

Scientific Show StopperEndocrinology

Related articles

Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallmann syndrome
Anna Cariboni, … , Fanny Mann, Christiana Ruhrberg
Anna Cariboni, … , Fanny Mann, Christiana Ruhrberg
Published May 18, 2015
Citation Information: J Clin Invest. 2015;125(6):2413-2428. https://doi.org/10.1172/JCI78448.
View: Text | PDF
Research Article Development Endocrinology Genetics Neuroscience Article has an altmetric score of 57

Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallmann syndrome

  • Text
  • PDF
Abstract

Individuals with an inherited deficiency in gonadotropin-releasing hormone (GnRH) have impaired sexual reproduction. Previous genetic linkage studies and sequencing of plausible gene candidates have identified mutations associated with inherited GnRH deficiency, but the small number of affected families and limited success in validating candidates have impeded genetic diagnoses for most patients. Using a combination of exome sequencing and computational modeling, we have identified a shared point mutation in semaphorin 3E (SEMA3E) in 2 brothers with Kallmann syndrome (KS), which causes inherited GnRH deficiency. Recombinant wild-type SEMA3E protected maturing GnRH neurons from cell death by triggering a plexin D1–dependent (PLXND1-dependent) activation of PI3K-mediated survival signaling. In contrast, recombinant SEMA3E carrying the KS-associated mutation did not protect GnRH neurons from death. In murine models, lack of either SEMA3E or PLXND1 increased apoptosis of GnRH neurons in the developing brain, reducing innervation of the adult median eminence by GnRH-positive neurites. GnRH neuron deficiency in male mice was accompanied by impaired testes growth, a characteristic feature of KS. Together, these results identify SEMA3E as an essential gene for GnRH neuron development, uncover a neurotrophic function for SEMA3E in the developing brain, and elucidate SEMA3E/PLXND1/PI3K signaling as a mechanism that prevents GnRH neuron deficiency.

Authors

Anna Cariboni, Valentina André, Sophie Chauvet, Daniele Cassatella, Kathryn Davidson, Alessia Caramello, Alessandro Fantin, Pierre Bouloux, Fanny Mann, Christiana Ruhrberg

×

Fertility and fragrance: another cause of Kallmann syndrome
Shlomo Melmed
Shlomo Melmed
Published May 18, 2015
Citation Information: J Clin Invest. 2015;125(6):2275-2278. https://doi.org/10.1172/JCI82061.
View: Text | PDF
Commentary Article has an altmetric score of 1

Fertility and fragrance: another cause of Kallmann syndrome

  • Text
  • PDF
Abstract

Kallmann syndrome is an inherited deficiency of gonadotropin-releasing hormone (GnRH) that is characterized by hypogonadism with delayed or absent puberty and dysfunctional olfaction. While Kallmann syndrome–associated mutations have been identified in some sets of patients, for many of these individuals, the underlying cause remains unknown. In this issue of the JCI, Cariboni and colleagues identify mutations in semaphorin 3E (SEMA3E) in two brothers with Kallmann syndrome. In animal models, loss of SEMA3E signaling recapitulated phenotypes of the probands and resulted in enhanced GnRH neuron death during development. The results of this study offer important insight into the development of Kallmann syndrome and provide tools for elucidating mutations that underlie complex hormonal phenotypes.

Authors

Shlomo Melmed

×
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

On 2 Facebook pages
27 readers on Mendeley
See more details
Picked up by 4 news outlets
Blogged by 2
Posted by 6 X users
On 3 Facebook pages
75 readers on Mendeley
See more details